{
  "paper_metadata": {
    "pmid": "36198883",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper discusses variants in the TTR gene, specifically the V30M and Ser52Pro mutations, and provides clinical data on affected individuals."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.89G>A",
      "protein_notation": "p.Val30Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 15,
        "demographics": "Aged 27\u201369 years, 9 females (56%)",
        "phenotype": "Hereditary transthyretin amyloidosis (ATTRv) with symptoms including neuropathy, cognitive complaints, and strokes."
      },
      "penetrance_data": {
        "total_carriers_observed": 15,
        "affected_count": 14,
        "unaffected_count": 1,
        "uncertain_count": null,
        "penetrance_percentage": 93.33,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case #1",
          "age_at_evaluation": 48,
          "age_at_onset": 41,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Neuropathy",
          "evidence_sentence": "Case #1 had a V30M mutation and presented with neuropathy."
        },
        {
          "individual_id": "Case #2",
          "age_at_evaluation": 36,
          "age_at_onset": 33,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Neuropathy",
          "evidence_sentence": "Case #2 had a V30M mutation and presented with neuropathy."
        },
        {
          "individual_id": "Case #3",
          "age_at_evaluation": 37,
          "age_at_onset": 26,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Neuropathy",
          "evidence_sentence": "Case #3 had a V30M mutation and presented with neuropathy."
        },
        {
          "individual_id": "Case #4",
          "age_at_evaluation": 50,
          "age_at_onset": 39,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Neuropathy",
          "evidence_sentence": "Case #4 had a V30M mutation and presented with neuropathy."
        },
        {
          "individual_id": "Case #5",
          "age_at_evaluation": 38,
          "age_at_onset": 30,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Neuropathy",
          "evidence_sentence": "Case #5 had a Ser52Pro mutation and presented with neuropathy."
        },
        {
          "individual_id": "Case #6",
          "age_at_evaluation": 46,
          "age_at_onset": 36,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Neuropathy",
          "evidence_sentence": "Case #6 had a V30M mutation and presented with neuropathy."
        },
        {
          "individual_id": "Case #7",
          "age_at_evaluation": 41,
          "age_at_onset": 30,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Neuropathy",
          "evidence_sentence": "Case #7 had a V30M mutation and presented with neuropathy."
        },
        {
          "individual_id": "Case #8",
          "age_at_evaluation": 36,
          "age_at_onset": 30,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Neuropathy",
          "evidence_sentence": "Case #8 was homozygous for V30M mutation and presented with neuropathy."
        },
        {
          "individual_id": "Case #9",
          "age_at_evaluation": 41,
          "age_at_onset": 30,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Neuropathy",
          "evidence_sentence": "Case #9 had a V30M mutation and presented with neuropathy."
        },
        {
          "individual_id": "Case #10",
          "age_at_evaluation": 41,
          "age_at_onset": 36,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Neuropathy",
          "evidence_sentence": "Case #10 had a V30M mutation and presented with neuropathy."
        },
        {
          "individual_id": "Case #11",
          "age_at_evaluation": 56,
          "age_at_onset": 41,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Neuropathy",
          "evidence_sentence": "Case #11 had a V30M mutation and presented with neuropathy."
        },
        {
          "individual_id": "Case #12",
          "age_at_evaluation": 41,
          "age_at_onset": 36,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Neuropathy",
          "evidence_sentence": "Case #12 had a V30M mutation and presented with neuropathy."
        },
        {
          "individual_id": "Case #13",
          "age_at_evaluation": 56,
          "age_at_onset": 41,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Neuropathy",
          "evidence_sentence": "Case #13 had a V30M mutation and presented with neuropathy."
        },
        {
          "individual_id": "Case #14",
          "age_at_evaluation": 68,
          "age_at_onset": 52,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Neuropathy",
          "evidence_sentence": "Case #14 had a V30M mutation and presented with neuropathy."
        },
        {
          "individual_id": "Case #15",
          "age_at_evaluation": 69,
          "age_at_onset": 56,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Neuropathy",
          "evidence_sentence": "Case #15 had a V30M mutation and presented with neuropathy."
        },
        {
          "individual_id": "Case #16",
          "age_at_evaluation": 63,
          "age_at_onset": 29,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Neuropathy",
          "evidence_sentence": "Case #16 had a V30M mutation and presented with neuropathy."
        }
      ],
      "functional_data": {
        "summary": "The V30M mutation is known to cause misfolding of the TTR protein, leading to amyloid deposition.",
        "assays": []
      },
      "segregation_data": "The V30M mutation segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "high",
      "source_location": "Table 1",
      "additional_notes": "The Ser52Pro mutation was noted in one case but is less common.",
      "key_quotes": [
        "The most common mutation is V30M (p.Val30Met), but more than 130 mutations are recognized producing a broad range of phenotypes.",
        "The earliest and predominant manifestation of ATTRv was neuropathy in all cases."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Patients\u2019 characteristics",
      "variants_extracted": 1
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted from the main text and tables."
  }
}